Buffer Dam for XCell SureLock and XCell II from Invitrogen
Rabbit Anti-Histone H2A Polyclonal Antibody, Unconjugated from BioVision
Rabbit Anti-Human EGFr, phospho (Tyr992) Concentrate Polyclonal Antibody, Unconjugated from Invitrogen
Rabbit Anti-Rat Synapsin I, phospho (Ser603) Monoclonal Antibody, Clone PS603 from Invitrogen
Biology Products:(Date:11/25/2009)..., SANDIEGO,Nov.25/PRNewswire-FirstCall/--ArdeaB...rryD.Quart,Pharm.D.,presidentandchiefexecutiveoffi...reConference. , ,Presentationdetailsareasfollows:...Tuesday,December1,2009,Time:2:00p.m.EasternTime,Lo...href=,http://www.corporate-ir.net/ireye/,target=,...
(Date:11/24/2009)... The New York investment ban...(ASX:NEU) has agreed an AU$6.7 mil convertible not...stor. The private placement was arranged by KTA Ca...visor. , New York (PRWEB)...estment bank KTA Capital, LLC ("KTA Capital&q...
(Date:11/24/2009)..., ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Sigma-...ttheNASDAQOMXconferenceonTuesday,December1stat1:45...tenvialiveaudiobroadcastovertheInternetavailableat...Userscanclickthe"Webcast"icontoaccessthisfile. ,...ifeScienceandHighTechnologycompany.Itschemicalandb...
(Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/-...ompanyfocusedondevelopingandcommercializingnovelpa...onno,PresidentandChiefExecutiveOfficer,isscheduled...erence,tobeheldDecember1-2,2009atTheNewYorkPalaceH...higlieri,ChiefFinancialOfficer,willbeavailabletore...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3